Inaktiver Wert

Albany Molecular Research, Inc. Aktie

Aktien

Dauer

Zeitraum

Stil

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17.01.18
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	04.01.18
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19.12.17
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30.11.17
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09.11.17

Manager	Titel	Alter	Seit
Philip W Macnabb CEO	Chief Executive Officer	-	01.05.23
Meera Khullar CMP	Compliance Officer	-	01.03.19
Prakash Pandian CTO	Chief Tech/Sci/R&D Officer	-	01.06.18

Aufsichtsräte	Titel	Alter	Seit
Dean Mihas BRD	Director/Board Member	57	-
Sean Cunningham BRD	Director/Board Member	48	-
William McMullan BRD	Director/Board Member	46	-

Sektor

	% 1. Jan.	Kap.
IQVIA HOLDINGS INC.	-2.43%	41.35 Mrd.
LONZA GROUP AG	+42.15%	40.38 Mrd.
MODERNA, INC.	+1.32%	39.05 Mrd.
CELLTRION, INC.	-14.19%	26.67 Mrd.
ICON PUBLIC LIMITED COMPANY	+1.42%	24.07 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-25.00%	18.36 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-4.53%	11.68 Mrd.
MEDPACE HOLDINGS, INC.	+20.28%	11.6 Mrd.
UNITED THERAPEUTICS CORPORATION	+7.70%	11.15 Mrd.